* . * . . .



NHS Cancer Vaccine Launch Pad expanded to include trial for patients with advanced type of skin cancerPatients with an advanced type of skin melanoma in England will be given fast-track access to a “revolutionary” new cancer vaccine as part of an NHS trial.The vaccine, known as iSCIB1+ (ImmunoBody), helps the immune system recognise cancer cells and therefore better respond to immunotherapy treatment. Continue reading…



Source link : https://www.theguardian.com/society/2025/apr/14/melanoma-patients-in-england-get-fast-track-access-to-cancer-vaccine

Author : Tobi Thomas Health and inequalities correspondent

Publish date : 2025-04-13 23:00:00

Copyright for syndicated content belongs to the linked Source.

Exit mobile version